Margot is counsel in the London Corporate/M&A practice. She advises listed companies, private companies, funds and investment banks on a broad range of matters, including public and private M&A, joint ventures, reorganisations and corporate advisory matters.
Margot has experience across a range of industries, with a particular focus on healthcare, consumer products and infrastructure. She completed a client secondment to The Royal Bank of Scotland in 2013.
Prior to joining White & Case, Margot worked for one of the UK's magic circle law firms for 8 years and also worked for a top tier law firm in New Zealand.
Sainsbury's on its proposed £15 billion merger with Asda.*
Reckitt Benckiser on the US$17.9 billion acquisition of Mead Johnson Nutrition Company.*
UBM plc on its takeover by Informa plc for £3.8 billion.*
Alinda Capital Partners on its recommended takeover of Energy Assets Group plc for £198 million.*
Macquarie on the acquisition of a 50 percent interest in the Race Bank Offshore Wind Farm from Ørsted for £1.6 billion.*
Anglo American on the US$1.7 billion sale of its niobium and phosphates divisions to China Molybdenum.*
Novartis on its asset swap with GSK, where Novartis sold its vaccines business to GSK for US$7.1 billion, Novartis acquired GSK's oncology business for US$16 billion and the parties entered into a joint venture in respect of the parties’ consumer health businesses.*
Takeda Pharmaceuticals on the US$578 million sale of its global respiratory product portfolio to AstraZeneca.*
UniCredit Group on its aborted £5.45 billion global asset management joint venture with Banco Santander, Warburg Pincus and General Atlantic.*
Reckitt Benckiser on its transformational restructuring to separate its Health and Hygiene Home products into separate global business units.*
JP Morgan Private Bank on a cross-border merger to implement its Brexit planning reorganisation.*
*Recent experience before joining White & Case includes